Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-2761-2024

Medline Procedure kits labeled as: 1) CIRCUMCISION SET, Pack Number CIT6335; 2) CIRCUMCISION TRAY , Pack Number CIT6135BH; 3) CIRCUMCISION TRAY , Pack Number CIT2465; 4) CIRCUMCISION TRAY , Pack Number CIT4920; 5) CIRCUMCISION TRAY , Pack Number CIT7455; 6) CIRCUMCISION TRAY , Pack Number DYNDA3045; 7) CIRCUMCISION TRAY , Pack Number DYNDL1889; 8) CIRCUMCISION TRAY , Pack Number CIT7455H ; 9) CIRCUMCISION TRAY W/1.3 CLAMP , Pack Number CIT6075; 10) CIRCUMCISON TRAY, Pack Number CIT7380; 11) HOSPITAL CIRCUMCISION T, Pack Number CIT2825; 12) CIRCUMCISION TRAY , Pack Number CIT6135A ; 13) CIRCUMCISION TRAY , Pack Number CIT6135B ; 14) NICU CIRCUMCISION SET, Pack Number CIT6900;

Publicado el 4 de septiembre de 2024 · Inicio del retiro: 8 de abril de 2024

Resumen

FDA registra el retiro Z-2761-2024 de dispositivos médicos de Clase II, publicado el 4 de septiembre de 2024 e iniciado el 8 de abril de 2024. Empresa responsable: MEDLINE INDUSTRIES, LP - Northfield; Estado: En curso; Lote: CIT6335, Lot Number 22IBT528 ; CIT6135BH, Lot Number 22OBI417 ; CIT6135BH, Lot Number 22FBX794 ; CIT6135BH, Lot Number 23CBQ475 ; CIT6135BH, Lot Number 23CBT677 ; CIT6135BH, Lot Number 23EBP345 ; CIT6135BH, Lot Number 23LBI785 ; CIT6135BH, Lot Number 24BBT038 ; CIT2465, Lot Number 21BBH212 ; CIT4920, Lot Number 22GBS036 ; CIT4920, Lot Number 22IBF469 ; CIT4920, Lot Number 23CBG366 ; CIT4920, Lot Number 23IBL492 ; CIT7455, Lot Number 23GBV732 ; DYNDA3045, Lot Number 23FBO420 ; DYNDA3045, Lot Number 23GBI869 ; DYNDA3045, Lot Number 23IBR354 ; DYNDL1889, Lot Number 23GLB117 ; DYNDL1889, Lot Number 23ILA455 ; CIT7455H , Lot Number 23GBV732 ; CIT6075, Lot Number 22DBD285 ; CIT6075, Lot Number 22EBV624 ; CIT6075, Lot Number 23ABM531 ; CIT6075, Lot Number 23CBC554 ; CIT6075, Lot Number 23CBH405 ; CIT6075, Lot Number 23EBC481 ; CIT6075, Lot Number 23EBS480 ; CIT6075, Lot Number 23FBT595 ; CIT6075, Lot Number 23IBT726 ; CIT7380, Lot Number 22GBM440 ; CIT7380, Lot Number 24BBM689 ; CIT2825, Lot Number 22JBI550 ; CIT2825, Lot Number 23BBR929 ; CIT2825, Lot Number 23GBD786 ; CIT2825, Lot Number 23IBL941 ; CIT6135A , Lot Number 21CBG443 ; CIT6135A , Lot Number 21CBG766 ; CIT6135B , Lot Number 22OBI417 ; CIT6135B , Lot Number 22FBX794 ; CIT6135B , Lot Number 23CBQ475 ; CIT6135B , Lot Number 23CBT677 ; CIT6135B , Lot Number 23EBP345 ; CIT6135B , Lot Number 23LBI785 ; CIT6135B , Lot Number 24BBT038 ; CIT6900, Lot Number 21LBB097 ; CIT6900, Lot Number 22GBF169 ; CIT6900, Lot Number 22IBR336 ; CIT6900, Lot Number 23DBE643. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

Medical convenience kits contain plastic syringes affected by the FDA Safety Alert issued on March 19, 2024. Leaks, breakage, and/ other quality issues have been identified that may pose a risk to patient health.

Qué hacer

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
MEDLINE INDUSTRIES, LP - Northfield
Distribuidor
Worldwide
Lote
CIT6335, Lot Number 22IBT528 ; CIT6135BH, Lot Number 22OBI417 ; CIT6135BH, Lot Number 22FBX794 ; CIT6135BH, Lot Number 23CBQ475 ; CIT6135BH, Lot Number 23CBT677 ; CIT6135BH, Lot Number 23EBP345 ; CIT6135BH, Lot Number 23LBI785 ; CIT6135BH, Lot Number 24BBT038 ; CIT2465, Lot Number 21BBH212 ; CIT4920, Lot Number 22GBS036 ; CIT4920, Lot Number 22IBF469 ; CIT4920, Lot Number 23CBG366 ; CIT4920, Lot Number 23IBL492 ; CIT7455, Lot Number 23GBV732 ; DYNDA3045, Lot Number 23FBO420 ; DYNDA3045, Lot Number 23GBI869 ; DYNDA3045, Lot Number 23IBR354 ; DYNDL1889, Lot Number 23GLB117 ; DYNDL1889, Lot Number 23ILA455 ; CIT7455H , Lot Number 23GBV732 ; CIT6075, Lot Number 22DBD285 ; CIT6075, Lot Number 22EBV624 ; CIT6075, Lot Number 23ABM531 ; CIT6075, Lot Number 23CBC554 ; CIT6075, Lot Number 23CBH405 ; CIT6075, Lot Number 23EBC481 ; CIT6075, Lot Number 23EBS480 ; CIT6075, Lot Number 23FBT595 ; CIT6075, Lot Number 23IBT726 ; CIT7380, Lot Number 22GBM440 ; CIT7380, Lot Number 24BBM689 ; CIT2825, Lot Number 22JBI550 ; CIT2825, Lot Number 23BBR929 ; CIT2825, Lot Number 23GBD786 ; CIT2825, Lot Number 23IBL941 ; CIT6135A , Lot Number 21CBG443 ; CIT6135A , Lot Number 21CBG766 ; CIT6135B , Lot Number 22OBI417 ; CIT6135B , Lot Number 22FBX794 ; CIT6135B , Lot Number 23CBQ475 ; CIT6135B , Lot Number 23CBT677 ; CIT6135B , Lot Number 23EBP345 ; CIT6135B , Lot Number 23LBI785 ; CIT6135B , Lot Number 24BBT038 ; CIT6900, Lot Number 21LBB097 ; CIT6900, Lot Number 22GBF169 ; CIT6900, Lot Number 22IBR336 ; CIT6900, Lot Number 23DBE643
Clasificación de riesgo
Class II
Área (FDA)
device
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿Medline Procedure kits labeled as: 1) CIRCUMCISION SET, Pack Number CIT6335; 2) CIRCUMCISION TRAY , Pack Number CIT6135BH; 3) CIRCUMCISION TRAY , Pack Number CIT2465; 4) CIRCUMCISION TRAY , Pack Number CIT4920; 5) CIRCUMCISION TRAY , Pack Number CIT7455; 6) CIRCUMCISION TRAY , Pack Number DYNDA3045; 7) CIRCUMCISION TRAY , Pack Number DYNDL1889; 8) CIRCUMCISION TRAY , Pack Number CIT7455H ; 9) CIRCUMCISION TRAY W/1.3 CLAMP , Pack Number CIT6075; 10) CIRCUMCISON TRAY, Pack Number CIT7380; 11) HOSPITAL CIRCUMCISION T, Pack Number CIT2825; 12) CIRCUMCISION TRAY , Pack Number CIT6135A ; 13) CIRCUMCISION TRAY , Pack Number CIT6135B ; 14) NICU CIRCUMCISION SET, Pack Number CIT6900; fue retirado del mercado?

Sí. FDA publicó el retiro Z-2761-2024 el 4 de septiembre de 2024. Peligro reportado: Medical convenience kits contain plastic syringes affected by the FDA Safety Alert issued on March 19, 2024. Leaks, breakage, and/ other quality issues have been identified that may pose a risk to patient health.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit